Paula Jackson

Paula Jackson is an Associate Principal Scientist at Redx Pharma since August 2020, previously holding titles of Senior Scientist and Scientist within the same company. From November 2019 to August 2020, Paula worked as a Chemist at Cancer Research UK Manchester Institute and was a Scientist at Redx Pharma from September 2014 to November 2019. Currently, Paula focuses on the design and development of a novel small molecule SHP2 inhibitor in the oncology branch of Redx Pharma. Paula holds a Master's Degree (MChem) in Chemistry from the University of York, obtained in 2014.